Détail de l'auteur
Auteur Vidal J |
Documents disponibles écrits par cet auteur (6)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Marechal X ; Villoutreix B ; Vidal J ; Miuzzo M ; Bianchini E ; Sandona D ; Betto R ; Reboud-Ravaux M | 2011The majority of sarcoglycanopathies are associated with missense mutations in each of the four sarcoglycans (a, b, g and d) that mainly generate misfolded proteins.These are identified by the endoplasmic reticulum quality control system and elim[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Basse N ; Couchoux H ; Génin E ; Abbaci K ; Blaineau S ; Vala C ; Bouvier-Durand M ; Le Ravalec V ; Vidal J ; Reboud-Ravaux M ; Berthier C | 2008Inhibiting the proteasome appears as a promising therapeutic tool for the treatment of muscle pathologies, including muscle atrophy and several myopathies. We have designed new proteasome inhibitors based on the cyclic natural inhibitor TMC-95A.[...]Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Sandona D ; Gastaldello S ; Franzoso S ; Fanin M ; Angelini C ; Vidal J ; Basse N ; Reboud-Ravaux M ; Betto R | 2008Sarcoglycanopathies are progressive muscle wasting disorders caused by genetic defects of four proteins, ?-, ?-, ?-, and ?-sarcoglycan, elements of a key transmembrane complex of striated muscle. The proper assembly of the sarcoglycan complex re[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Basse N ; Pagano M ; Reboud-Ravaux M ; Felten D ; Vanderesse R ; Ferrier-Berthelot A ; Piguel S ; Vidal J | 2005Communication n° 670 Introduction : Currently, there is no safe and effective medicines available to treat muscle atrophy. Proteasome inhibitors appear to be valuable candidates since they reduce the rate of proteolysis in skeletal muscle atroph[...]Article